Retagliptin
- Generic Name
- Retagliptin
- Drug Type
- Small Molecule
- Chemical Formula
- C19H18F6N4O3
- CAS Number
- 1174122-54-3
- Unique Ingredient Identifier
- 328C4R3P9L
Overview
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
Background
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
Indication
用于改善成人2型糖尿病患者的血糖控制。 ①单药：本品单药可配合饮食控制和运动，改善成人2型糖尿病患者的血糖控制。 ②与盐酸二甲双胍联合使用：在单独使用盐酸二甲双胍血糖控制不佳时，本品可与盐酸二甲双胍联合使用，配合饮食和运动改善成人2型糖尿病患者的血糖控制。
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath